Clinical Study on the Impact of Diabetes Mellitus on Vulnerable Plaque Characteristics on Coronary CTA in Patients with Coronary Artery Disease

Suzhou Hospital of Traditional Chinese Medicine0 个研究点开始时间: 2026年8月1日最近更新: 2026年8月3日

适应症

试验速览

暂无简介。

•Aged 18–75 years, regardless of gender;
•Have available coronary CTA images;
•Hospitalized patients with a confirmed diagnosis of coronary artery disease (CAD).

•Presence of severe cardiac dysfunction, including prior or current New York Heart Association (NYHA) functional class = III and/or left ventricular ejection fraction (LVEF) = 50%;
•Presence of severe hepatic or renal dysfunction, including serum alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) levels > 3 times the upper limit of normal, estimated glomerular filtration rate (eGFR) < 30 mL/(min·1.73 m²), or undergoing renal replacement therapy;
•Presence of other significant cardiac diseases including primary valvular heart disease, severe arrhythmias, myocarditis, pericardial disease, congenital heart disease, or prior coronary artery bypass grafting (CABG);
•Presence of severe hematologic diseases, malignant tumors, or thyroid dysfunction;
•Poor image quality on coronary CTA.

发起方

Suzhou Hospital of Traditional Chinese Medicine